REUTERS - Ranbaxy Laboratories Ltd (RANB.NS), India's top drugmaker by sales, said it has launched Absorica, a drug used to treat recalcitrant acne, in the United States.
The drug is in-licensed from Cipher Pharmaceuticals Inc DND.TO, said Ranbaxy, controlled by Japan's Daiichi Sankyo Co (4568.T), on Monday. (Reporting by Kaustubh Kulkarni in Mumbai)
Trending On Reuters
Some 30,000 Indian soldiers guarding the border with Bangladesh have a new mandate under Prime Minister Narendra Modi's government this year - stop cattle from crossing illegally into the Muslim-majority neighbour. Full Article
India's $100 billion solar push draws foreign firms as locals take backseat Full Article